Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN950586 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-UDP-Gal:betaGlcNAc beta 1,3-Galactosyltransferase, Polypeptide 5 (B3GALT5) (AA 64-91), (N-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- N-Term, AA 64-91
- Vial size
- 0.4 mL
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Beta1,3-galactosyltransferases-4/5 are novel tumor markers for gynecological cancers.
Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.
Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines.
Comparative analysis of retroviral and native promoters driving expression of beta1,3-galactosyltransferase beta3Gal-T5 in human and mouse tissues.
Seko A, Kataoka F, Aoki D, Sakamoto M, Nakamura T, Hatae M, Yonezawa S, Yamashita K
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):43-50
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2009;30(1):43-50
Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept.
Hamshere ML, Green EK, Jones IR, Jones L, Moskvina V, Kirov G, Grozeva D, Nikolov I, Vukcevic D, Caesar S, Gordon-Smith K, Fraser C, Russell E, Breen G, St Clair D, Collier DA, Young AH, Ferrier IN, Farmer A, McGuffin P, Wellcome Trust Case Control Consortium., Holmans PA, Owen MJ, O'Donovan MC, Craddock N
The British journal of psychiatry : the journal of mental science 2009 Jul;195(1):23-9
The British journal of psychiatry : the journal of mental science 2009 Jul;195(1):23-9
Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines.
Lin CH, Fan YY, Chen YY, Wang SH, Chen CI, Yu LC, Khoo KH
Glycobiology 2009 Apr;19(4):418-27
Glycobiology 2009 Apr;19(4):418-27
Comparative analysis of retroviral and native promoters driving expression of beta1,3-galactosyltransferase beta3Gal-T5 in human and mouse tissues.
Mare L, Trinchera M
The Journal of biological chemistry 2007 Jan 5;282(1):49-57
The Journal of biological chemistry 2007 Jan 5;282(1):49-57
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB